A body of animal and clinical trials [30, 31] have shown that DEX decreases cytokine (TNF-α, IL-6) secretion after endotoxin injection and that DEX reduced the mortality rate in endotoxemia-induced shock rat models in a dose-dependent manner. This evidence concerns the gene IL6 and serum lipopolysaccharide activity.